APA (7th ed.) Citation

Gando, A., Alexay, S., Galán Núñez, J. P., Cano, L. N., Diez, R. A., & Costa, L. A. (2021). Comment on Hadadi et al., Does recombinant human erythropoietin administration in critically ill COVID‐19 patients have miraculous therapeutic effects? J. Med. Virol. 2020; 92: 915‐918. Journal of medical virology, 93(5), 2626-2627. https://doi.org/10.1002/jmv.26879

Chicago Style (17th ed.) Citation

Gando, Alejandro, Sofia Alexay, Juan P. Galán Núñez, Lucía N. Cano, Roberto A. Diez, and Luis A. Costa. "Comment on Hadadi Et Al., Does Recombinant Human Erythropoietin Administration in Critically Ill COVID‐19 Patients Have Miraculous Therapeutic Effects? J. Med. Virol. 2020; 92: 915‐918." Journal of Medical Virology 93, no. 5 (2021): 2626-2627. https://doi.org/10.1002/jmv.26879.

MLA (9th ed.) Citation

Gando, Alejandro, et al. "Comment on Hadadi Et Al., Does Recombinant Human Erythropoietin Administration in Critically Ill COVID‐19 Patients Have Miraculous Therapeutic Effects? J. Med. Virol. 2020; 92: 915‐918." Journal of Medical Virology, vol. 93, no. 5, 2021, pp. 2626-2627, https://doi.org/10.1002/jmv.26879.